4.7 Review

Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia

Sylvie Belleville et al.

Summary: This study examines the dose-response relationship in multidomain interventions for dementia prevention and finds that the optimal dose is about half of the potentially available sessions. Factors such as gender, age, frailty, education level, and dementia risk influence individuals' response to the dose.

ALZHEIMERS & DEMENTIA (2022)

Article Nursing

Effects of a multicomponent intervention to slow mild cognitive impairment progression: A randomized controlled trial

Qiao-hong Yang et al.

Summary: The study evaluated the effects of a multicomponent intervention on Chinese patients with mild cognitive impairment. The results showed that the intervention had beneficial effects on cognitive function, physical function, depression symptoms, and quality of life, slowing the progression of the disease.

INTERNATIONAL JOURNAL OF NURSING STUDIES (2022)

Article Health Care Sciences & Services

Intervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial

Michelle Gray et al.

Summary: This study aims to investigate the effects of a 2-year digital lifestyle intervention on the risk of AD among middle-aged and older adults. The intervention utilizes a web-based health coaching program to target modifiable lifestyle factors and reduce the risk of AD.

JMIR RESEARCH PROTOCOLS (2022)

Article Cardiac & Cardiovascular Systems

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial

Sarah Parish et al.

Summary: The study found that aspirin did not have a significant effect on the risk of dementia. More trials or meta-analyses with larger incidence numbers are needed to determine if there are any modest benefits of aspirin use on dementia.

EUROPEAN HEART JOURNAL (2022)

Article Neurosciences

Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial

Daisuke Asaoka et al.

Summary: This study investigated the effect of the probiotic strain Bifidobacterium breve MCC1274 (A1) on cognitive function and brain atrophy in older patients with mild cognitive impairment (MCI). The results showed that probiotics supplementation improved some aspects of cognitive function and slowed down the progression of brain atrophy, especially in patients with significant atrophy. However, there were no significant changes in the overall composition of the gut microbiota.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Health Care Sciences & Services

Factors Predicting Engagement of Older Adults With a Coach-Supported eHealth Intervention Promoting Lifestyle Change and Associations Between Engagement and Changes in Cardiovascular and Dementia Risk: Secondary Analysis of an 18-Month Multinational Randomized Controlled Trial

Nicola Coley et al.

Summary: This study aimed to examine older adults' engagement with a digital health intervention and its associations with changes in cardiovascular and dementia risk factors. The findings showed that higher engagement was associated with greater improvement in risk factors. However, individuals with limited computer experience, lower education levels, or poorer cognition tended to have lower engagement.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Article Medicine, General & Internal

Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline A Randomized Clinical Trial

Claudia Schwarz et al.

Summary: This 12-month randomized, double-masked, placebo-controlled clinical trial found that longer-term spermidine supplementation did not modify memory and biomarkers in participants with subjective cognitive decline.

JAMA NETWORK OPEN (2022)

Review Geriatrics & Gerontology

Public knowledge of the influence of modifiable cardiovascular risk factors on dementia: a systematic literature review and meta-analysis

Laurence Lloyd Parial et al.

Summary: This systematic review explored the awareness of the general public on the influence of modifiable cardiovascular risk factors on dementia. Despite the identified association between CVRFs and dementia, overall knowledge on this relationship is low among the public. Higher education, better economic status, and prior contact with dementia patients positively influence dementia risk knowledge.

AGING & MENTAL HEALTH (2021)

Article Clinical Neurology

Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index

Kay Deckers et al.

Summary: Individuals in early dementia prevention trials may benefit differently from interventions based on their initial risk levels, as measured by the LIBRA score. The FINGER intervention was effective in reducing LIBRA scores over time, regardless of baseline demographics or cognition. LIBRA may serve as a useful surrogate/intermediate endpoint and surveillance tool to monitor intervention success during trial execution.

ALZHEIMERS & DEMENTIA (2021)

Article Geriatrics & Gerontology

Effect of oral health intervention on cognitive decline in community-dwelling older adults: A randomized controlled trial

Chiaki Matsubara et al.

Summary: The study aimed to investigate the effects of oral health intervention on cognitive functions in community-dwelling subjects with mild cognitive decline. The results showed that oral health intervention by dental hygienists can be effective for improving executive function in cognitive function.

ARCHIVES OF GERONTOLOGY AND GERIATRICS (2021)

Article Clinical Neurology

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease A Truncated Randomized Phase 2b/3 Clinical Trial

Reisa Sperling et al.

Summary: This study reveals that atabecestat treatment in preclinical Alzheimer disease patients is associated with dose-related cognitive worsening and neuropsychiatric adverse events. However, after stopping treatment, cognitive status returned to baseline and the frequency of adverse events returned to placebo levels.

JAMA NEUROLOGY (2021)

Article Medicine, Research & Experimental

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline

Xiaoran Liu et al.

Summary: The MIND study aims to investigate the effects of the MIND diet on cognitive function in individuals at risk for Alzheimer's disease through a 3-year randomized controlled trial. Unique features of the study include testing a dietary pattern in an at-risk population, providing key components of the MIND diet to participants, and conducting MRI scans to potentially provide mechanistic evidence on the effects of the diet. Results from the study will be crucial for the development of dietary guidelines for the prevention of AD.

CONTEMPORARY CLINICAL TRIALS (2021)

Article Medicine, General & Internal

Donanemab in Early Alzheimer's Disease

Mark A. Mintun et al.

Summary: In this study, donanemab showed improved composite scores for cognition and daily living activities compared to placebo in patients with early Alzheimer's disease at 76 weeks, although secondary outcomes varied. Longer and larger trials are needed to further explore the efficacy and safety of donanemab in Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Clinical Neurology

Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial

Nicola Coley et al.

Summary: This study explored factors associated with participation and adherence in a 3-year RCT of dementia prevention, revealing that older individuals with higher anxiety were less likely to participate, while those with higher income, family history, or more fear of dementia were more likely to do so. Factors such as cognitive function and perceived social support predicted better adherence to the interventions.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Clinical Neurology

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Chad J. Swanson et al.

Summary: BAN2401-G000-201 trial aimed to establish the effective dose and observe the treatment effect. While not meeting the primary endpoint at 12 months, results at 18 months demonstrated reduction in brain amyloid and improvement across multiple clinical and biomarker endpoints.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Neurosciences

Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk

Alina Solomon et al.

Summary: The study demonstrates that a multidomain lifestyle intervention can reduce the risk of cognitive impairment in older adults, indicating the preventive potential of the intervention.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Clinical Neurology

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns et al.

Summary: The study aimed to identify participants at risk of developing mild cognitive impairment due to Alzheimer's disease using the BRAA algorithm and evaluate the safety and efficacy of low-dose pioglitazone. Results showed that pioglitazone did not delay the onset of mild cognitive impairment.

LANCET NEUROLOGY (2021)

Review Neurosciences

The informed road map to prevention of Alzheimer Disease: A call to arms

Eric McDade et al.

Summary: Alzheimer's Disease prevention trials aim to intervene before significant neuronal damage occurs, with limitations including challenges in translating animal models, lack of asymptomatic disease target validation, uncertain causality in pathophysiologic changes, and limited biomarker validation for new targets. The field is advancing in developing specific biomarkers, understanding amyloid and tau pathology from asymptomatic to symptomatic stages, and creating interventions to slow or reverse amyloid pathology. Calls for more appropriate prevention animal models, biomarkers, and outcome measures for human asymptomatic prevention trials are made to accelerate AD prevention efforts.

MOLECULAR NEURODEGENERATION (2021)

Article Biochemistry & Molecular Biology

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Stephen Salloway et al.

Summary: Results from the phase 2/3 clinical trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease show no cognitive benefits despite reduced amyloid plaques and other key biomarkers with gantenerumab. Solanezumab did not show cognitive benefits and even led to greater decline on some measures, with no benefits on downstream biomarkers. Gantenerumab significantly reduced amyloid plaques and some biomarkers but did not slow cognitive decline in symptomatic DIAD patients.

NATURE MEDICINE (2021)

Editorial Material Multidisciplinary Sciences

Phenotyping Alzheimer's disease with blood tests

Kaj Blennow

SCIENCE (2021)

Article Health Care Sciences & Services

The Internet-Based Conversational Engagement Clinical Trial (I-CONECT) in Socially Isolated Adults 75+Years Old: Randomized Controlled Trial Protocol and COVID-19 Related Study Modifications

Kexin Yu et al.

Summary: The I-CONECT is a multi-site, assessor-blind, randomized controlled behavioral intervention trial aiming to improve cognitive function in socially isolated adults through video chat intervention. The study protocol includes remote assessments, genetic testing, and speech analysis to measure the impact of social interactions on cognitive decline and Alzheimer's disease.

FRONTIERS IN DIGITAL HEALTH (2021)

Article Geriatrics & Gerontology

Computerized Cognitive Training for Older Adults at Higher Dementia Risk due to Diabetes: Findings From a Randomized Controlled Trial

Alex Bahar-Fuchs et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)

Article Geriatrics & Gerontology

Exploring the Specificity, Synergy, and Durability of Auditory and Visual Computer Gameplay Transfer Effects in Healthy Older Adults

Mark E. Faust et al.

JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES (2020)

Article Nutrition & Dietetics

Randomized placebo-controlled study of the memory effects of pomegranate juice in middle-aged and older adults

Prabha Siddarth et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)

Article Geriatrics & Gerontology

Effects of Cognitive Rehabilitation on Cognition, Apathy, Quality of Life, and Subjective Complaints in the Elderly: A Randomized Controlled Trial

Genoveva Montoya-Murillo et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)

Article Multidisciplinary Sciences

Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results

Emily A. Largent et al.

PLOS ONE (2020)

Article Geriatrics & Gerontology

Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster-randomized controlled trials

Liang-Kung Chen et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)

Article Clinical Neurology

World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

Miia Kivipelto et al.

ALZHEIMERS & DEMENTIA (2020)

Review Medicine, General & Internal

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

Gill Livingston et al.

LANCET (2020)

Article Public, Environmental & Occupational Health

Physical exercise for prevention of dementia (EPD) study: background, design and methods

Enzo Iuliano et al.

BMC PUBLIC HEALTH (2019)

Letter Medicine, General & Internal

Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease

David Henley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease

Michael F. Egan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Sport Sciences

Resistance training enhances delayed memory in healthy middle-aged and older adults: A randomised controlled trial

Kieran J. Marston et al.

JOURNAL OF SCIENCE AND MEDICINE IN SPORT (2019)

Article Neurosciences

Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial

Takashi Tarumi et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Geriatrics & Gerontology

Does social interaction influence the effect of cognitive intervention program? A randomized controlled trial using Go game

Ai Iizuka et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)

Article Geriatrics & Gerontology

Original Study Older Adults' Reasons for Participating in an eHealth Prevention Trial: A Cross-Country, Mixed-Methods Comparison

Nicola Coley et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)

Article Clinical Neurology

A randomized clinical trial to evaluate home-based assessment of people over 75 years old

Mary Sano et al.

ALZHEIMERS & DEMENTIA (2019)

Article Clinical Neurology

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

Cristina Lopez Lopez et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)

Article Geriatrics & Gerontology

Effects of Combined Physical and Cognitive Exercises on Cognition and Mobility in Patients With Mild Cognitive Impairment: A Randomized Clinical Trial

Hiroyuki Shimada et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)

Article Obstetrics & Gynecology

Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial

Byung-Koo Yoon et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2018)

Article Medicine, General & Internal

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease

Lawrence S. Honig et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Effect of Aspirin on Disability-free Survival in the Healthy Elderly

J. J. McNeil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

Louise Bowman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Clinical Neurology

Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease

Miia Kivipelto et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Geriatrics & Gerontology

Effects of Tai Chi on Cognition and Fall Risk in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial

Somporn Sungkarat et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)

Article Medicine, General & Internal

Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment

Susan M. Resnick et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study

Severine Sabia et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Article Medicine, General & Internal

Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study

Severine Sabia et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Article Medicine, Research & Experimental

Building research in diet and cognition: The BRIDGE randomized controlled trial

Lisa Tussing-Humphreys et al.

CONTEMPORARY CLINICAL TRIALS (2017)

Review Health Care Sciences & Services

Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis

Cathrien R. L. Beishuizen et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2016)

Article Medicine, General & Internal

Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults The LIFE Randomized Trial

Kaycee M. Sink et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Medicine, General & Internal

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Jackson T. Wright et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Editorial Material Cell Biology

The A4 Study: Stopping AD Before Symptoms Begin?

Reisa A. Sperling et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Geriatrics & Gerontology

A RANDOMIZED CONTROLLED ALZHEIMER'S DISEASE PREVENTION TRIAL'S EVOLUTION INTO AN EXPOSURE TRIAL: THE PREADVISE TRIAL

R. J. Kryscio et al.

JOURNAL OF NUTRITION HEALTH & AGING (2013)

Article Medicine, General & Internal

Frailty in elderly people

Andrew Clegg et al.

LANCET (2013)

Article Geriatrics & Gerontology

Effectiveness of cognitive training for Chinese elderly in Hong Kong

Timothy Kwok et al.

CLINICAL INTERVENTIONS IN AGING (2013)

Article Clinical Neurology

Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues

J. Scott Roberts et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2013)

Article Public, Environmental & Occupational Health

Exergaming and Older Adult Cognition A Cluster Randomized Clinical Trial

Cay Anderson-Hanley et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2012)

Review Cell Biology

Aging with multimorbidity: A systematic review of the literature

Alessandra Marengoni et al.

AGEING RESEARCH REVIEWS (2011)

Article Medicine, General & Internal

Resistance Training and Executive Functions A 12-Month Randomized Controlled Trial

Teresa Liu-Ambrose et al.

ARCHIVES OF INTERNAL MEDICINE (2010)

Article Geriatrics & Gerontology

Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial

Antonio Muscari et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)

Review Endocrinology & Metabolism

Estrogen therapy: is time of initiation critical for neuroprotection?

Barbara B. Sherwin

NATURE REVIEWS ENDOCRINOLOGY (2009)

Review Public, Environmental & Occupational Health

Dementia Prevention: Methodological Explanations for Inconsistent Results

Nicola Coley et al.

EPIDEMIOLOGIC REVIEWS (2008)

Article Medicine, General & Internal

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease - A randomized trial

Nicola T. Lautenschlager et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Medicine, General & Internal

Long-term effects of cognitive training on everyday functional outcomes in older adults

Sherry L. Willis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Medicine, Research & Experimental

Recruitment of the elderly into a pharmacologic prevention trial: The Ginkgo Evaluation of Memory Study experience

Annette L. Fitzpatrick et al.

CONTEMPORARY CLINICAL TRIALS (2006)